103-LB: Real-World Persistence, Adherence, Health Care Resource Utilization, and Costs in People with Type 2 Diabetes (T2D) Switching from Basal Insulin (BI) to Second-Generation BI (Insulin Glargine 300 U/mL [Gla-300]) vs. First-Generation BI (Insulin Glargine 1
2020 ◽
Vol 19
◽
pp. 100215
2015 ◽
Vol 29
(4)
◽
pp. 529-533
◽
2020 ◽
Vol 26
(12)
◽
pp. 1506-1516